terbutaline has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gross, CR; Ingbar, DH; Lasnier, JM; Schmitz, LS; Wangensteen, OD | 1 |
| Auld, SC; Banerji, A; Channell, N; Druey, KM; Eisch, AR; Maleque, N; Matheny, M | 1 |
2 other study(ies) available for terbutaline and cardiovascular agents
| Article | Year |
|---|---|
Terbutaline stimulates alveolar fluid resorption in hyperoxic lung injury.
Topics: Adrenergic beta-Agonists; Animals; Body Fluids; Cardiovascular Agents; Hyperoxia; Lung; Male; Organ Size; Ouabain; Pulmonary Alveoli; Pulmonary Edema; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical; Terbutaline | 1996 |
Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series.
Topics: Aged; Capillary Leak Syndrome; Cardiovascular Agents; COVID-19; COVID-19 Vaccines; Disease Progression; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Pandemics; Risk Factors; SARS-CoV-2; Terbutaline; Theophylline | 2021 |